No data are currently available about the efficacy of Vivotif Oral (typhoid vaccine) in individuals with blood dyscrasias, leukaemia, lymphoma or any type of malignant neoplasm affecting the bone marrow or lymphatic system. These individuals may fail to develop protection because of their disturbed immune functions.
In the case of acute febrile illnesses and acute gastro-intestinal illness as well as during and up to 3 days after treatment with antibiotics, Vivotif Oral should not be taken due to possible inhibition of the growth of the vaccine organisms.
The capsules must be swallowed whole and not chewed because of the destruction of the organism by gastric acid.
See also “Interactions with Other Medicines.”
Pregnancy - Category B2
Studies in animals are inadequate but available data show no evidence of an increased occurrence of foetal damage.
Last reviewed on RxList: 9/30/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Vivotif Oral Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.